Investors bought shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading hours on Thursday. $126.18 million flowed into the stock on the tick-up and $107.82 million flowed out of the stock on the tick-down, for a money net flow of $18.36 million into the stock. Of all companies tracked, UnitedHealth Group had the 24th highest net in-flow for the day. UnitedHealth Group traded down ($1.58) for the day and closed at $140.80

Several research firms have recently issued reports on UNH. Mizuho boosted their price target on shares of UnitedHealth Group from $150.00 to $156.00 and gave the company a “buy” rating in a research report on Wednesday, April 20th. Wedbush reaffirmed an “outperform” rating and set a $138.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, April 19th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, May 18th. Leerink Swann reaffirmed an “outperform” rating and set a $150.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, April 19th. Finally, Morgan Stanley reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, May 18th. Two analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $146.02.

The company has a market capitalization of $133.87 billion and a price-to-earnings ratio of 22.64. The company has a 50-day moving average of $137.20 and a 200 day moving average of $126.00.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 19th. The healthcare conglomerate reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.09. During the same period last year, the business posted $1.46 earnings per share. The business earned $44.50 billion during the quarter, compared to analysts’ expectations of $43.96 billion. The company’s revenue for the quarter was up 24.5% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Inc. will post $7.89 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Friday, June 17th were issued a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.78%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Wednesday, June 15th.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Thursday, June 16th. The shares were sold at an average price of $138.58, for a total value of $692,900.00. Following the completion of the transaction, the director now directly owns 72,229 shares of the company’s stock, valued at $10,009,494.82. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,500 shares of the firm’s stock in a transaction on Friday, June 10th. The shares were sold at an average price of $139.80, for a total transaction of $768,900.00. Following the completion of the transaction, the director now directly owns 59,019 shares of the company’s stock, valued at $8,250,856.20. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have bought and sold shares of UNH. Dimensional Fund Advisors LP raised its position in UnitedHealth Group by 3.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,108,013 shares of the healthcare conglomerate’s stock worth $365,706,000 after buying an additional 92,985 shares during the period. Rail Splitter Capital Management LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $5,800,000. Cedar Hill Associates LLC raised its position in UnitedHealth Group by 1.8% in the fourth quarter. Cedar Hill Associates LLC now owns 118,311 shares of the healthcare conglomerate’s stock worth $13,918,000 after buying an additional 2,086 shares during the period. Jennison Associates LLC raised its position in UnitedHealth Group by 96.4% in the fourth quarter. Jennison Associates LLC now owns 785,534 shares of the healthcare conglomerate’s stock worth $92,410,000 after buying an additional 385,632 shares during the period. Finally, I.G. Investment Management LTD. raised its position in UnitedHealth Group by 52.2% in the fourth quarter. I.G. Investment Management LTD. now owns 66,389 shares of the healthcare conglomerate’s stock worth $7,810,000 after buying an additional 22,779 shares during the period.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.